European Commission says it is contractually entitled to doses from two UK plants making AstraZeneca/Oxford University vaccine
Brussels on Wednesday demanded that tens of millions of British-made coronavirus vaccines be diverted from the UK to make up a supply shortfall in the jabs in the EU.
The European Commission said it was contractually entitled to doses from two UK plants making the AstraZeneca/Oxford University vaccine as its row with the British-Swedish pharmaceutical giant deepened.
The British Government said it had a deal with AstraZeneca to supply 100 million doses of the vaccine with agreed delivery schedules.
British sources said that, once the UK factories had fulfilled their commitment to Britain, AstraZeneca would be free to supply other countries – something the firm’s CEO, Pascal Soriot, confirmed in an interview on Tuesday.